Equities

Master Style PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Master Style PCL

Actions
Health CareHealth Care Providers
  • Price (THB)8.85
  • Today's Change-0.20 / -2.21%
  • Shares traded6.01m
  • 1 Year change-67.22%
  • Beta--
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Master Style Public Company Limited is a Thailand-based company. The Company operates a cosmetic surgery hospital under the name of Masterpiece Hospital. It operates through two segments: hospital business, and trading of cosmetic products. The Company provides a full range of surgical services, such as rhinoplasty, eyebrow lift and face contouring surgery, breast surgery, liposuction and reshaping surgery, eye surgery, facial restructuring surgery, hair transplants and hair treatment, as well as skin care and laser treatments with modern medical technology and techniques. Its skin care services are categorized into four fields: laser service, face reshaping service, treatment service, and slimming services. The Company provides permanent hair transplantation Follicular Unit Extraction (FUE), which is a modern hair transplant technique using hair follicle cells from the occipital area to be planted in the desired area. Its subsidiary is Master Innovation Company Limited.

  • Revenue in THB (TTM)2.05bn
  • Net income in THB371.17m
  • Incorporated2013
  • Employees819.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aesthetic Connect PCL462.65m89.53m1.53bn86.0017.010.908714.443.310.25760.25761.334.820.266153.521,566.465,379,703.005.1517.565.3919.4750.2951.4919.3527.409.62860.460.0026---24.6118.74-27.6228.22----
Thonburi Medical Centre PCL1.11bn149.95m1.74bn311.0011.601.988.941.567.747.7457.3545.421.0993.0210.613,574,584.0014.699.5317.3411.5337.0033.6513.497.574.88--0.008128.59-13.441.5433.2041.490.088--
Safe Fertility Group Pcl699.20m124.63m1.91bn194.0015.361.1311.142.740.410.412.305.560.35957.5041.573,604,122.006.268.546.689.1655.4752.9617.4118.5314.06--0.0366---2.18-2.60-17.21-7.61-18.39--
Aikchol Hospital PCL1.75bn139.91m1.99bn1.34k14.250.93428.731.140.93330.933311.7014.240.706231.149.101,313,675.005.638.106.319.2819.1820.637.9810.566.021,458.180.005150.55-1.871.07-32.72-0.93978.13-0.9051
Nakornthon Hospital PCL1.98bn203.48m2.17bn958.001.561.096.401.102.602.604.883.720.92446.0915.262,069,653.009.48--12.12--28.80--10.26--1.7133.730.0406---0.8836---17.21------
Ladprao General Hospital PCL2.57bn166.40m2.65bn877.0015.921.346.011.030.23110.23113.582.740.848831.367.892,935,026.007.038.138.6710.1426.5726.568.289.571.5010.880.162469.187.438.6923.01-6.68-2.177.57
Ratchaphruek Hospital PCL1.14bn173.40m2.69bn783.0015.211.5610.672.360.32340.32342.123.160.597930.8911.131,454,308.009.1011.649.9013.2533.5037.4515.2319.583.03402.980.002155.53-3.056.62-6.4612.34-26.9515.68
Master Style PCL2.05bn371.17m2.73bn819.007.360.80185.221.331.231.236.7911.290.49418.28159.522,503,143.008.9519.049.8122.6657.4557.4718.1122.500.4225--0.1577--11.3938.8325.5053.5372.52--
Mahachai Hospital PCL6.44bn132.68m3.46bn4.54k26.051.534.170.53660.82930.829340.2514.100.554732.106.431,418,665.001.021.361.542.0318.3221.561.852.910.3861.480.674435.07-0.002321.46-75.13-9.04-33.31-3.58
Nonthavej Hospital PCL2.37bn280.50m3.62bn1.40k12.891.327.621.521.751.7514.8317.180.768333.269.821,696,156.009.0810.5510.0011.6827.1528.7611.8213.244.74--0.0060.360.51741.94-6.96-3.0217.24-2.81
Rajthanee Hospital PCL2.64bn252.58m3.87bn1.33k15.021.829.081.460.85910.85918.987.100.615431.965.321,982,343.005.5220.887.6229.5222.1538.118.9725.040.59465.230.380972.0316.649.1117.484.4922.86-8.64
Patrangsit Healthcare Group PCL2.44bn304.05m3.87bn1.55k12.731.809.521.591.011.018.137.160.995427.497.561,578,876.0012.4114.2914.2817.8124.6426.6612.4612.324.62743.660.0034--6.329.54-2.7933.20-17.14--
Wattanapat Hospital Trang PCL2.21bn315.89m4.03bn533.0012.432.216.841.820.46250.46253.212.610.719528.0110.144,149,617.0010.496.8812.288.1832.0228.3814.5710.680.878810.630.378130.3839.2321.92200.13--12.08-47.68
Data as of Feb 06 2026. Currency figures normalised to Master Style PCL's reporting currency: Thai Baht THB

Institutional shareholders

1.98%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 30 Jun 20254.92m1.63%
AIA Investment Management HK Ltd.as of 30 Sep 2025403.90k0.13%
Maybank Asset Management Sdn. Bhd.as of 31 Jul 2025321.00k0.11%
Talis Asset Management Co. Ltd.as of 30 Sep 2025213.30k0.07%
Dimensional Fund Advisors LPas of 30 Jun 202550.90k0.02%
Nomura Asset Management Singapore Ltd.as of 12 Sep 202337.71k0.01%
Dimensional Fund Advisors Ltd.as of 30 Nov 202515.92k0.01%
Thanachart Fund Management Co., Ltd.as of 30 Sep 20250.000.00%
Eastspring Asset Management (Thailand) Co., Ltd.as of 30 Sep 20250.000.00%
More ▼
Data from 30 Jun 2025 - 28 Nov 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.